17-alpha-hydroxyprogesterone

(redirected from 17-Hydroxyprogesterone)
Also found in: Wikipedia.

17-al·pha-hy·drox·y·pro·ges·ter·one

(-ăl′fə-hī-drŏk′sē-prō-jĕs′tə-rōn′)
n.
A compound produced by the adrenal glands and often used therapeutically as a progestogen when such a steroid is needed for parenteral administration.
References in periodicals archive ?
Contract awarded for 17-hydroxyprogesterone oh neonatal screening methodology: fluorometric assay (delphia); use: laboratory diagnosis; reagent: yes; area: immunology;
This eight person single dose exploratory study showed that NBI-77860 was effective in reducing the key biomarkers of adrenocorticotropic hormone (ACTH) and 17-hydroxyprogesterone androgen (17-OHP).
A random 17-hydroxyprogesterone (17-OHP) was within reference intervals, and estradiol was at the lower limit of the reference interval (28 pg/mL).
Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy.
DALLAS - The drug 17-hydroxyprogesterone caproate, or 17P, is not effective for reducing the risk of preterm delivery in nulliparous women with a cervix length less than the 10th percentile, findings from a randomized placebo-controlled study involving 657 women have shown.
However, despite the questions about cotton collection and its effect on accuracy, there have been studies that compared salivary hormone levels with plasma levels, and the following have been found to be favorably comparable for the most part: cortisol, DHEA, 17-hydroxyprogesterone, estriol, estradiol, aldosterone, progesterone, androstenedione, and testosterone in males.
Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
Internists should become aware of the event surrounding the FDA approval of Makena, a commercial preparation of 17-hydroxyprogesterone, an injectable agent to reduce premature delivery in at-risk mothers to be.
The diagnosis is confirmed by an elevated plasma 17-hydroxyprogesterone (17-OHP) level.
b) 11-Deoxy, 11-deoxycortisol; Andro, androstenedione; 17-OHP, 17-hydroxyprogesterone.
dehydroepiandrosterone sulfate (DHEA-S), serum baseline 17-hydroxyprogesterone (17-0HP), urinary metanephrine, normetanephrine, vanilylmandelic acid (VMA) excretion, low-dose 2 mg dexamethasone suppression tests, plasma aldosterone and renin activity.